Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_L02BG
Extra metadata
List of similar endpoints to
L02BG Aromatase inhibitors
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5045 | 5004 | 41 |
| Unadjusted prevalence (%) | 1.94 | 3.41 | 0.04 |
| Mean age at first event (years) | 63.64 | 63.81 | 42.59 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.10 | 7.55 [5.35, 10.65] | 1.2e-30 | 362 |
| 15 years | 0.05 | 7.73 [5.54, 10.80] | 3.1e-33 | 358 |
| 5 years | 0.01 | 10.91 [8.12, 14.66] | 1.0e-56 | 214 |
| 1 year | 0.00 | 4.48 [2.70, 7.44] | 6.8e-9 | 19 |
Index endpoint: RX_L02BG – L02BG Aromatase inhibitors
GWS hits:
before L02BG Aromatase inhibitors
after L02BG Aromatase inhibitors
Loading survival analyses plot
Loading survival analyses table